Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Submitted by
admin
on May 22, 2017 - 9:45am
Source:
Fierce Pharma
News Tags:
Amgen
romosozumab
Radius Health
UCB Pharma
Tymlos
osteoporosis
Headline:
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Do Not Allow Advertisers to Use My Personal information
